NeuroStar® TMS Therapy
FDA-cleared, non-medication depression treatment
(855) 940-4867
Medically reviewed on by
Regional Medical Director Greater St. Louis
SPRAVATO® is not recommended during pregnancy. If you’re trying to become pregnant, your healthcare provider will advise you not to take SPRAVATO®. Anyone with the possibility of becoming pregnant should take precautions to avoid pregnancy while on a SPRAVATO® treatment plan. Should you become pregnant, let your SPRAVATO® provider know immediately.
Studies conducted on pregnant animals
treated with ketamine found that the drug did cause fetal harm, which is the driving reason that SPRAVATO® should not be taken during pregnancy. Because of the danger to human fetuses, there isn’t enough data to determine the exact risks of ketamine in human pregnancy. There’s also a lack of data to understand whether ketamine is safe for breastfeeding, so SPRAVATO® is not recommended for breastfeeding mothers.
It can feel disheartening to find out that SPRAVATO® isn’t safe while you’re pregnant or breastfeeding. A dissociative anesthetic, esketamine nasal spray is a major breakthrough as the first such medication to receive FDA approval for treatment-resistant depression (TRD) and major depressive disorder with suicidal ideation (MDSI).
Some antidepressants are generally safe for pregnancy. However, doctors may hesitate to prescribe oral antidepressants to pregnant women, including selective serotonin reuptake inhibitors (SSRIs), which are widely known to be the safer options for pregnancy. While they aren’t thought to cause birth defects, SSRIs can cause neonatal adaptation syndrome in newborn babies.
Jitters, irritability, and respiratory distress can all be signs of this syndrome. Researchers think it may occur due to in-utero exposure to the SSRI or withdrawal from the SSRI. Despite being worrisome, this syndrome typically resolves on its own within a month. Still, some mothers may feel nervous about the risk of their baby being born with this syndrome.
Living with depression while trying to keep a fetus healthy is a challenge. The problem with avoiding antidepressants entirely during pregnancy is that mental health conditions like depression can negatively impact a fetus, too. Depression can make it difficult to attend important prenatal appointments, take the recommended vitamins, get adequate rest, and eat a nutritious diet. Severe depression can come with risks to you or your baby’s safety.
Remember that it’s just as important to take care of
you
while pregnant as it is to care for your fetus. And even though SPRAVATO® is unsafe during pregnancy or breastfeeding, there is another option. Transcranial magnetic stimulation (TMS) is considered safe for pregnant and breastfeeding mothers.
TMS works by delivering gentle magnetic pulses to targeted areas of the brain. These magnetic fields stimulate nerve cells, which can help ease symptoms of depression. Unlike SPRAVATO®, which is taken intranasally, TMS therapy is drug-free and the magnetic fields go nowhere near the uterus. Studies have also found that TMS therapy is safe for lactating women, so you can receive treatment when breastfeeding.
There’s a time commitment to consider when you’re planning for TMS therapy. You’ll need to come to a TMS therapy center, like Greenbrook, five times a week for six to nine weeks. Sessions typically take between 18 and 45 minutes, and there aren’t any restrictions on what you can do afterward. Plus, at Greenbrook, we offer flexible scheduling to help you fit treatments into your daily life.
To find out more about managing depression while pregnant,
schedule a no-cost consultation with Greenbrook. We’re here to help you navigate mental health no matter where you are in life.
Thanks for subscribing to our list!
Take our short quiz to see if TMS therapy or nasal esketamine could be right for you
Subscribe for mental health, self-care, and TMS therapy and nasal esketamine updates for those affected by treatment-resistant depression or OCD.
Thank you for subscribing to our email list!
Oops, there was an error adding your subscription.
Please try again later.
By providing your email address, you are consenting to receive blog updates from Greenbrook TMS Inc. You may unsubscribe from these alerts at any time by following the “unsubscribe” link at the bottom of email alerts. At Greenbrook TMS Inc. we take the privacy and security of your personal information seriously. To learn more about how we protect your personal information, please refer to our Privacy Policy.
Greenbrook supports an accessible internet. If you have any questions about our accessibility features, please contact us at
(855) 940-4867 or info@greenbrooktms.com.
NeuroStar Adult Indications for Use
The NeuroStar Advanced Therapy System is indicated for the treatment of depressive episodes and for decreasing anxiety symptoms for those who may exhibit comorbid anxiety symptoms in adult patients suffering from Major Depressive Disorder (MDD) and who failed to achieve satisfactory improvement from previous antidepressant medication treatment in the current episode.
The NeuroStar Advanced Therapy System is intended to be used as an adjunct for the treatment of adult patients suffering from Obsessive-Compulsive Disorder (OCD).
NeuroStar Adolescent Indications for Use
NeuroStar Advanced Therapy is indicated as an adjunct for the treatment of Major Depressive Disorder (MDD) in adolescent patients (15-21).
Important Safety Information
NeuroStar Advanced Therapy is only available by prescription. A doctor can help decide if NeuroStar Advanced Therapy is right for you. Patients’ results may vary.
The most common side effect is pain or discomfort at or near the treatment site. These events are transient; they occur during the TMS treatment course and do not occur for most patients after the first week of treatment. There is a rare risk of seizure associated with the use of TMS therapy (<0.1% per patient).
Visit neurostar.com for full safety and prescribing information.
Important Safety Information
What is the most important information I should know about SPRAVATO®?
SPRAVATO® can cause serious side effects, including:
Do not take SPRAVATO® if you:
If you are not sure if you have any of the above conditions, talk to your healthcare provider before taking SPRAVATO®.
Before you take SPRAVATO®, tell your healthcare provider about all of your medical conditions, including if you:
Tell your healthcare provider about all the medicines that you take, including prescription and over-the-counter medicines, vitamins and herbal supplements. Taking SPRAVATO® with certain medicine may cause side effects.
Especially tell your healthcare provider if you take central nervous system (CNS) depressants, psychostimulants, or monoamine oxidase inhibitors (MAOIs) medicine. Keep a list of them to show to your healthcare provider and pharmacist when you get a new medicine.
How will I take SPRAVATO®?
What should I avoid while taking SPRAVATO®?
Do not drive, operate machinery, or do anything where you need to be completely alert after taking SPRAVATO®. Do not take part in these activities until the next day following a restful sleep. See “What is the most important information I should know about SPRAVATO®?”
What are the possible side effects of SPRAVATO®?
SPRAVATO® may cause serious side effects including:
See “What is the most important information I should know about SPRAVATO®?”
Increased blood pressure. SPRAVATO® can cause a temporary increase in your blood pressure that may last for about 4 hours after taking a dose. Your healthcare provider will check your blood pressure before taking SPRAVATO® and for at least 2 hours after you take SPRAVATO®. Tell your healthcare provider right away if you get chest pain, shortness of breath, sudden severe headache, change in vision, or seizures after taking SPRAVATO®.
Problems with thinking clearly. Tell your healthcare provider if you have problems thinking or remembering.
Bladder problems. Tell your healthcare provider if you develop trouble urinating, such as a frequent or urgent need to urinate, pain when urinating, or urinating frequently at night.
The most common side effects of SPRAVATO® include:
If these common side effects occur, they usually happen right after taking SPRAVATO® and go away the same day.
These are not all the possible side effects of SPRAVATO®.
Call your doctor for medical advice about side effects. You may report side effects to Johnson & Johnson at 1-800-526-7736, or to the FDA at 1-800-FDA-1088.
What is SPRAVATO® (esketamine) CIII nasal spray?
SPRAVATO® is a prescription medicine used:
SPRAVATO® is not for use as a medicine to prevent or relieve pain (anesthetic). It is not known if SPRAVATO® is safe or effective as an anesthetic medicine.
It is not known if SPRAVATO® is safe and effective for use in preventing suicide or in reducing suicidal thoughts or actions. SPRAVATO® is not for use in place of hospitalization if your healthcare provider determines that hospitalization is needed, even if improvement is experienced after the first dose of SPRAVATO®.
It is not known if SPRAVATO® is safe and effective in children.
Please see full Prescribing Information, including Boxed WARNINGS, and Medication Guide for SPRAVATO® and discuss any questions you may have with your healthcare provider.
All Rights Reserved | Greenbrook TMS NeuroHealth Centers.